17-21 October


Virtual Zoom Meeting

Conference Schedule

Regulatory Agilities

Regulatory agilities and further accelerating patient access to safe and effective medicines and vaccines

Post Approval Changes

Reliance, Convergence/Harmonization and Risk Based Approaches to PACs


Delivering products with the same quality standards to patients everywhere


ICH – The Foundations of Success

Biotherapeutics & Advanced Therapies

Changing regulatory landscape of Biotherapeutics and Cell & Gene Therapies

Program Committee

Janis Bernat

Director, Scientific & Regulatory Affairs IFPMA

Sergio Cavalheiro Filho

Manager, Regulatory Affairs, IFPMA

Mümün Gencoglu

Manager, Regulatory Affairs IFPMA (more…)

Sarah Adam

Associate Director, Regulatory Affairs IFPMA (more…)

Greg Perry

Assistant Director General IFPMA   (more…)

Advisory Board

Asia Pacific Technical Regulatory Policy Roche Singapore Technical Operations

Director, Global Regulatory Policy Pfizer

Head Greater China and Intercontinental & Emerging Markets Regulatory Policy GSK

Director, Scientific & Regulatory Affairs IFPMA

Director and Head of Global Regulatory Affairs CEPI

Executive Director, Duke-NUS Senior Advisor, MOH

Head Asia Pacific Regulatory & Development Policy Novartis

Group Lead, Regulatory Convergence and Networks Team, WHO

Associate Director of Global Regulatory Science and Policy, China Team Sanofi

AVP Regulatory Affairs Lead Asia Pacific MSD

Director, Quality External Affairs - JAPAC Amgen

President of MIASA Malaysia & Chairman of the National Advocacy of